Robert Thomas Fremeau Jr. is Chief Scientific Officer at Vyant Bio, Inc. (VYNT). They have made 1 open-market trade across 1 company since 2021, most recently 2021-10-28.
CIK 0001894066
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VYNT | 1,000 | $678 |
Shares reported on the most recent Form 4, priced at the 2021-11-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VYNT | BUY | 2021-10-28 | 2021-11-17 | $2.19 | $2K | -11.6% | -24.1% | -44.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.